Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics has disclosed the setting of December 31, 2025, as the record date and established a shareholder register closure period to identify shareholders entitled to vote at the 15th Annual General Meeting of Shareholders.
📊 [Key Disclosure Details & Financial Figures]
- Record Date: December 31, 2025
- Shareholder Register Closure Period (Suspension of Entry of Change): January 1, 2026 – January 31, 2026
- Reason for Setting: Identification of voting shareholders for the 15th Annual General Meeting of Shareholders (AGM)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Identifying Eligible Shareholders and Monitoring Upcoming AGM Agenda Items
This disclosure establishes the record date and shareholder register closure period required to determine eligible voting shareholders for the 15th Annual General Meeting.
Following the confirmation of voting shareholders, tracking the specific meeting date, location, and submitted voting agenda items as the convening process moves forward is crucial for understanding upcoming governance decisions.
Relevant details can be verified in the subsequent ‘Decision on Calling of General Shareholders Meeting’ disclosure.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
